Speciality & Rare Disease Medicines – Global Sourcing

Ikris Health Plus specialises in facilitating global access to speciality and rare disease medicines for patients with limited treatment options. Developed by Ikris Pharma Network, the platform supports access to oncology biologics, genetic metabolic and orphan disease therapies through regulated pathways. When medicines are unavailable locally or not yet approved in certain regions, Ikris Health Plus enables access via legally permitted named patient programs. Each request is supported by valid prescriptions, medical justification and regulatory documentation to ensure compliance. The platform sources medicines exclusively from authorised manufacturers and verified suppliers, maintaining strict quality and traceability standards. Ikris Health Plus also supports Indian generics speciality drugs and clinical trial comparators for global healthcare needs. With EU operations in Belgium and Bulgaria, the platform ensures GDP-compliant sourcing, storage and international distribution. By combining regulatory expertise, ethical sourcing and global reach, Ikris Health Plus helps bridge the gap between rare disease patients and essential therapies worldwide.